Clinical Trial Update: An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

View source ↗

Summary

This was an open-label, multi-centre, non-interventional post-marketing surveillance study of AVANDAMET (rosiglitazone/metformin) to monitor safety and efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandamet (rosiglitazone/metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2011-03-15